ERBB2 and breast carcinoma: To explore the relationship between the MNX1 protein level and clinical prognosis of patients with HER2-positive breast cancer, we used tissue microarray data of 183 patients from our center to perform immunohistochemical staining and scored the patients by the staining intensity of MNX1.